Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tri-Staple 2.0 Reloads

K-Number: K202864 · 2020-10-28

ApplicantCovidien
Decision Date2020-10-28
Product CodeGDW
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Tri-Staple 2.0 Reloads is a medical device manufactured by Covidien. It received FDA 510(k) clearance on 2020-10-28 under approval number K202864. The device is classified under product code GDW. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tri-Staple 2.0 Reloads?

Tri-Staple 2.0 Reloads is a medical device that received FDA 510(k) clearance on 2020-10-28. It is manufactured by Covidien. The 510(k) number is K202864.

When was Tri-Staple 2.0 Reloads approved by the FDA?

Tri-Staple 2.0 Reloads received FDA 510(k) clearance on 2020-10-28, under approval number K202864.

What company makes Tri-Staple 2.0 Reloads?

Tri-Staple 2.0 Reloads is manufactured by Covidien.

What is the FDA product code for Tri-Staple 2.0 Reloads?

The FDA product code for Tri-Staple 2.0 Reloads is GDW.

Other Devices by Covidien

View all 61 devices →

Related Devices (Code: GDW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.